IMO the eventual announcement of a credible partnership is likely to cause Aruda and Aspire to halt their opportunistic unloading of shares during up days of higher volume in hopes of an up-listing and much higher volumes and prices where their interests can be replaced more profitably and in greater volume by institutions and larger investors who favor investments endorsed by experts like BP.
The good news, it seems to me, is that P is recruiting at an increasingly rapid rate and the not so good news is that OM recruitment seems to be slower. That fact may be motivating Aruda to sell into the upcoming mid term results, explaining the greater volume and flat price lately.
Mgmt's laser focus on partnerships is appropriate at this time and should they succeed the rapid price raise may surprise many people.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links